Study Exclusion reasons Remarks Reference(s)
NCT03015129, 2023 randomized controlled trial phase 2 study

Rubinstein MM Gynecol Oncol 2023; 169:64-69-. 10.1016/j.ygyno.2022.11.028

 
Konstantinopoulos, 2022 single-arm

Konstantinopoulos 10.1001/jamaoncol.2022.2181

  

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons